These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 7878951
1. Donor microchimerism is not responsible for the maintenance of tolerance to donor alloantigens in recipients tolerant of cardiac allografts. Hamano K, Rawsthorne M, Bushell A, Morris PJ, Wood KJ. Transplant Proc; 1995 Feb; 27(1):151-2. PubMed ID: 7878951 [No Abstract] [Full Text] [Related]
2. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients. Hamano K, Rawsthorne MA, Bushell AR, Morris PJ, Wood KJ. Transplantation; 1996 Sep 27; 62(6):856-60. PubMed ID: 8824489 [Abstract] [Full Text] [Related]
3. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling. Orosz CG, Huang EH, Bergese SD, Sedmak DD, Birmingham DJ, Ohye RG, VanBuskirk AM. J Heart Lung Transplant; 1997 Sep 27; 16(9):889-904. PubMed ID: 9322138 [Abstract] [Full Text] [Related]
4. Donor-type single MHC locus products combined with anti-CD4 MAb can induce tolerance to cardiac allografts which is dependent on active suppression. Saitovitch D, Morris PJ, Wood KJ. Transplant Proc; 1995 Feb 27; 27(1):119-20. PubMed ID: 7878844 [No Abstract] [Full Text] [Related]
5. The induction of transplantation tolerance using donor antigen and CD4 monoclonal antibody. Pearson TC, Madsen JC, Morris PJ, Wood KJ. Transplant Proc; 1990 Aug 27; 22(4):1955-6. PubMed ID: 2389494 [No Abstract] [Full Text] [Related]
6. A non-lymphocyte-depleting monoclonal antibody to the adhesion molecule LFA-1 (CD11a) prevents sensitization to alloantigens and effectively prolongs the survival of heart allografts. Nakakura EK, McCabe SM, Zheng B, Shorthouse RA, Scheiner TM, Blank G, Jardieu PM, Morris RE. Transplant Proc; 1993 Feb 27; 25(1 Pt 1):809-12. PubMed ID: 8438493 [No Abstract] [Full Text] [Related]
7. Induction of transplantation tolerance using a nondepleting anti-CD4 MAb and donor-specific transfusion before transplantation: evidence that a critical period of time is required for the development of immunological unresponsiveness. Saitovitch D, Bushell AR, Morris PJ, Wood KJ. Transplant Proc; 1995 Feb 27; 27(1):117-8. PubMed ID: 7878834 [No Abstract] [Full Text] [Related]
11. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration. Otomo N, Margenthaler JA, Motoyama K, Arima T, Shimizu Y, Lehmann M, Flye MW. J Surg Res; 2001 Jun 01; 98(1):59-65. PubMed ID: 11368539 [Abstract] [Full Text] [Related]
13. Induction of indefinite survival of fully allogeneic cardiac grafts and generation of regulatory cells by intratracheal delivery of alloantigens under blockade of the CD40 pathway. Uchida N, Shirasugi N, Akiyama Y, Matsumoto K, Shimazu M, Kitajima M, Hamano K, Aramaki O, Ikeda Y, Niimi M. Transplantation; 2003 Mar 27; 75(6):878-84. PubMed ID: 12660518 [Abstract] [Full Text] [Related]